Invention Grant
- Patent Title: Human Akt3 nucleic acid and uses thereof
- Patent Title (中): 人Akt3核酸及其用途
-
Application No.: US11063691Application Date: 2005-02-23
-
Publication No.: US07662628B2Publication Date: 2010-02-16
- Inventor: Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- Applicant: Kun Guo , Kenneth L. Clark , Yuri D. Ivashchenko , Marco Pagnoni
- Applicant Address: US NJ Bridgewater
- Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee: Aventis Pharmaceuticals Inc.
- Current Assignee Address: US NJ Bridgewater
- Main IPC: C12N15/09
- IPC: C12N15/09 ; C12Q1/70
Abstract:
The present invention relates to human Akt3 proteins and polypeptides. The invention also relates to isolated nucleic acids encoding human Akt3, to vectors containing them and to their therapeutic uses, in particular for gene therapy. Expression of Akt3 inhibits cell death associated with hypoxia, apoptosis or necrosis.
Public/Granted literature
- US20050142603A1 Akt nucleic acids, polypeptides, and uses thereof Public/Granted day:2005-06-30
Information query
IPC分类:
